Table 2.
Demographics and discharge characteristics for Registry of Neurological Endpoint Assessments among Patients with Ischemic and Hemorrhagic Stroke (REINAH) cohorts.
|
|
AISa (n=13,444) | ICHb (n=1809) | TIAc (n=3165) | SAHd (n=1221) | ||
| Demographics | ||||||
|
|
Age (years), median (IQR) | 69 (59-79) | 67 (55-78) | 71 (60-80) | 65 (53-76) | |
|
|
Female sex, n (%) | 6831 (50.8) | 836 (46.2) | 1767 (55.8) | 736 (60.3) | |
|
|
Race, n (%) | |||||
|
|
|
Asian | 760 (5.7) | 152 (8.4) | 104 (3.3) | 86 (7) |
|
|
|
Black | 3536 (26.3) | 428 (23.7) | 676 (21.4) | 213 (17.4) |
|
|
|
White | 8733 (65) | 1157 (64) | 2308 (72.9) | 867 (71) |
|
|
|
Other | 415 (3.1) | 72 (4) | 77 (2.4) | 55 (4.5) |
|
|
Hispanic, n (%) | 2018 (15) | 381 (21.1) | 427 (13.5) | 264 (21.6) | |
|
|
Top 30% ADIe, n (%) | 2528 (18.8) | 354 (19.6) | 538 (17) | 154 (12.6) | |
| Comorbidities | ||||||
|
|
Hypertension, n (%) | 10,629 (79.1) | 1456 (80.5) | 2551 (80.6) | 839 (68.7) | |
|
|
Diabetes, n (%) | 7165 (53.3) | 708 (39.1) | 1370 (43.3) | 282 (23.1) | |
|
|
Atrial fibrillation, n (%) | 7551 (56.2) | 460 (25.4) | 670 (21.2) | 152 (12.4) | |
|
|
Chronic kidney disease, n (%) | 4750 (35.3) | 607 (33.6) | 713 (22.5) | 163 (13.3) | |
|
|
Congestive heart failure, n (%) | 4651 (34.6) | 476 (26.3) | 663 (20.9) | 159 (13) | |
|
|
CCIf, median (IQR) | 5 (3-8) | 6 (3-9) | 4 (2-6) | 2 (0-4) | |
| Medication history, n (%) | ||||||
|
|
Antihypertensives | 4669 (34.7) | 557 (30.8) | 1203 (38) | 397 (32.5) | |
|
|
Antiplatelet | 4617 (34.3) | 454 (25.1) | 1232 (38.9) | 384 (31.4) | |
|
|
Anticoagulants (any) | 2153 (16) | 274 (15.1) | 577 (18.2) | 197 (16.1) | |
|
|
Statin | 4847 (36.1) | 533 (29.5) | 1289 (40.7) | 419 (34.3) | |
|
|
Warfarin | 497 (3.7) | 73 (4) | 144 (4.5) | 51 (4.2) | |
|
|
Novel oral anticoagulants | 1525 (11.3) | 181 (10) | 401 (12.7) | 98 (8) | |
| Imaging | ||||||
|
|
CTg availability, n (%) | 12,827 (95.4) | 1780 (98.4) | 2989 (94.4) | 1048 (85.8) | |
|
|
Hemorrhage volume, median (IQR) | N/Ah | 10.8 (2.9-32.5) | N/A | —i | |
|
|
MRIj availability, n (%) | 11,500 (85.5) | 1265 (69.9) | 2658 (84) | 340 (27.8) | |
|
|
CSVDk score, median (IQR) | — | 2 (1-3) | — | — | |
| Outcomes | ||||||
|
|
Length of stay, median (IQR) | 4 (2-6) | 6 (3-13) | 2 (2-4) | 2 (0-8) | |
|
|
Discharge disposition, n (%) | |||||
|
|
|
Home | 7967 (59.3) | 553 (30.6) | 2641 (83.4) | 391 (32) |
|
|
|
Deceased or hospice | 899 (6.7) | 484 (26.8) | 25 (0.8) | 104 (8.5) |
|
|
|
Skilled nursing facility | 1388 (10.3) | 207 (11.4) | 205 (6.5) | 63 (5.2) |
|
|
|
Long-term acute care | 266 (2) | 191 (10.6) | 9 (0.3) | 46 (3.8) |
|
|
|
Rehabilitative care | 2588 (19.3) | 346 (19.1) | 214 (6.8) | 84 (6.9) |
|
|
|
Other or transfer | 336 (2.5) | 28 (1.5) | 71 (2.2) | 533 (43.7) |
|
|
30 days, n (%) | — | 53 (2.9) | — | — | |
|
|
90 days, n (%) | — | 72 (4) | — | — | |
|
|
180 days, n (%) | — | 69 (3.8) | — | — | |
|
|
365 days, n (%) | — | 76 (4.2) | — | — | |
aAIS: acute ischemic stroke.
bICH: intracerebral hemorrhage.
cTIA: transient ischemic attack.
dSAH: subarachnoid hemorrhage.
eADI: Area Deprivation Index.
fCCI: Charlson Comorbidity Index.
gCT: computed tomography.
hN/A: not applicable.
iNot available.
jMRI: magnetic resonance imaging.
kCSVD: cerebral small vessel disease.